LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

Search

Codexis Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

2.45 0.41

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.43

Max

2.47

Pagrindiniai rodikliai

By Trading Economics

Pajamos

10M

-10M

Pardavimai

8.6M

21M

Pelnas, tenkantis vienai akcijai

-0.13

Pelno marža

-48.35

Darbuotojai

188

EBITDA

3.8M

-9.9M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+171.14% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-05-14

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-18M

209M

Ankstesnė atidarymo kaina

2.04

Ankstesnė uždarymo kaina

2.45

Naujienos nuotaikos

By Acuity

46%

54%

164 / 382 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Codexis Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-05-11 23:48; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

2025-05-11 23:46; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

2025-05-11 23:45; UTC

Rinkos pokalbiai

Oil Rises Amid Improved Market Mood -- Market Talk

2025-05-11 23:38; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Aristocrat Has Significant Firepower for M&A -- Market Talk

2025-05-11 23:36; UTC

Rinkos pokalbiai

Global Markets Uncertain About US-China Trade News -- Market Talk

2025-05-11 23:35; UTC

Rinkos pokalbiai

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

2025-05-11 23:33; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

2025-05-11 23:32; UTC

Svarbiausios naujienos

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

2025-05-11 22:44; UTC

Rinkos pokalbiai

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

2025-05-11 22:33; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

2025-05-11 20:19; UTC

Svarbiausios naujienos

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

2025-05-11 16:00; UTC

Svarbiausios naujienos

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

2025-05-11 11:00; UTC

Svarbiausios naujienos

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

2025-05-11 08:00; UTC

Svarbiausios naujienos

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

2025-05-11 01:00; UTC

Svarbiausios naujienos

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

2025-05-11 01:00; UTC

Svarbiausios naujienos

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

2025-05-10 21:54; UTC

Svarbiausios naujienos

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

2025-05-10 17:12; UTC

Svarbiausios naujienos

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

2025-05-10 15:41; UTC

Svarbiausios naujienos

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

2025-05-10 12:00; UTC

Svarbiausios naujienos

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

2025-05-10 09:30; UTC

Svarbiausios naujienos

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

2025-05-10 08:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-05-10 03:52; UTC

Svarbiausios naujienos

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

2025-05-09 23:51; UTC

Įsigijimai, susijungimai, perėmimai

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

2025-05-09 22:06; UTC

Rinkos pokalbiai

Arm Holdings Remains a Strong Growth Story -- Market Talk

2025-05-09 21:37; UTC

Svarbiausios naujienos

U.S. Sets August Deadline for Debt Ceiling -- WSJ

2025-05-09 21:10; UTC

Svarbiausios naujienos

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

2025-05-09 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-05-09 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-05-09 20:42; UTC

Svarbiausios naujienos

Stocks Get a Break From Trade Chaos -- WSJ

Akcijų palyginimas

Kainos pokytis

Codexis Inc Prognozė

Kainos tikslas

By TipRanks

171.14% į viršų

12 mėnesių prognozė

Vidutinis 6.67 USD  171.14%

Aukščiausias 11 USD

Žemiausias 4 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Codexis Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

4 ratings

3

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

2.25 / 2.53Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

164 / 382 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.